Brazilian drug regulator Anvisa approves the use of the Sinovac CoronaVac vaccine for children between the ages of 6 and 11 years. (Agência Brasil) COVID-19 pandemic in Brazil, COVID-19 vaccination in BrazilCOVID-19 pandemic link embed save